Switching to a once-daily bictegravir/lenacapavir (BIC/LEN) single-tablet regimen is generally well tolerated through 48 ...

At IDWeek 2026, Paul Sax, MD, and Cynthia Sears, MD, highlighted practice-changing developments bridging clinical infectious ...

Treatment-experienced patients with HIV and viremia achieve high virologic suppression with long-acting CAB/RPV.

The Infectious Disease Advisor team will be covering emerging research and key takeaways from IDWeek 2026, as well as ...

Patient COVID-19 status does not significantly alter the microbiology of device-associated hospital-acquired infections or ...

In people living with HIV and advanced solid tumors who are receiving antiretroviral therapy, treatment with nivolumab plus cabozantinib is safe.

During the 2024-2025 season, influenza vaccination effectively lowered the risk for hospitalization and severe inpatient outcomes among adults.

Products that promise relief from genital herpes are easy to order online, but none of them are approved to treat the infection.

Quadrivalent HPV vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth.

The quadrivalent HPV vaccine provides durable immune responses and protects against cervical disease in women with HIV.

Updated recommendations were presented for the management of UTIs in infants and children younger than 5 years in a recent guideline.

Congenital TORCH infections appear to be associated with an increased risk for intellectual disability and autism.